Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Washington Post: Complications of transvaginal mesh “not rare”

Posted in Vaginal Mesh

An article found on The Washington Post’s website clarified the current discussion surrounding the emerging number of complications seen in connection to the use of transvaginal mesh in the repair of pelvic organ prolapse.  The article summarized a statement issued by the U.S. Food and Drug Administration that reported that complications due to the use of transvaginal mesh kits are “not rare.”  Although this may seem like no cause for alarm, as “not rare” doesn’t indicate a serious epidemic or otherwise large shift in number of complications associated with transvaginal mesh, the situation is, in fact, more serious than the FDA’s summary implies.

In recent years, transvaginal mesh has been used more and more regularly as a constant stream of new versions of synthetic mesh kits has expanded in market development.  The kits, aimed at repairing the damages caused by pelvic organ prolapse, are far too commonly passed over in clinical testing for their objective safety in patients immediately following surgery and in long-term use.  With an estimated 30 to 50 percent of women suffering from pelvic organ prolapse (though only about 2% experience any symptoms),* it is a necessity to properly test the products that are used for the safe and effective repair of the prolapsed vaginal walls and pelvic organs.  While extensive testing was performed on some of the earlier versions of transvaginal mesh kits in their use for hernia surgeries, there is a supreme lack of research done to test the safety of their use in pelvic organ prolapse repair.

Medical professionals are finding that it is often the case that patients who use transvaginal mesh kits in the surgical repair of prolapsed pelvic organs have experienced a range of complications due to the products used.  The article in The Washington Post solidifies the worry as it states that no one single product line can be considered here as the trend has been that little research has been done on any of the currently used transvaginal mesh kits by any producers.

This serious issue has been a constant source of pain and suffering for patients everywhere, and we intend to help you or your loved ones win justice for the suffering caused by unsafe and under-tested products like transvaginal mesh.  Please contact us to receive a free consultation to determine if you are eligible to file a transvaginal mesh lawsuit.

Our team of transvaginal mesh lawyers may at your convenience be reached by phone at (855) 452-5529 or by e-mail at justinan@dangerousdrugs.us.  Our Transvaginal Mesh Lawsuit Information page is a great place to start if you have additional questions about Transvaginal Mesh.

*Another estimate published by The Lancet places the overall prevalence of genital prolapse at about 9% of women worldwide, affecting about 316 million women.  Such a discrepancy in reports of prevalence may be explained by the simple fact that many cases pelvic organ prolapse are asymptomatic and remain unnoticed.